Detalo Health ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  9.4% 9.8% 10.4% 8.1% 4.7%  
Credit score (0-100)  27 25 22 29 44  
Credit rating  BB BB BB BB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  1,477 547 1,292 2,132 2,771  
Gross profit  417 289 -249 1,029 679  
EBITDA  417 -16.2 -249 1,029 598  
EBIT  417 -16.2 -249 1,029 598  
Pre-tax profit (PTP)  407.6 -26.1 -267.8 1,027.3 590.6  
Net earnings  317.9 -20.9 -211.8 800.1 458.3  
Pre-tax profit without non-rec. items  408 -26.1 -268 1,027 591  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  368 347 135 935 794  
Interest-bearing liabilities  600 0.0 0.0 93.2 249  
Balance sheet total (assets)  1,894 680 782 1,266 1,290  

Net Debt  -121 -320 -253 -463 -118  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  1,477 547 1,292 2,132 2,771  
Net sales growth  0.0% -63.0% 136.3% 65.1% 30.0%  
Gross profit  417 289 -249 1,029 679  
Gross profit growth  0.0% -30.8% 0.0% 0.0% -34.0%  
Employees  0 0 0 0 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,894 680 782 1,266 1,290  
Balance sheet change%  0.0% -64.1% 15.1% 61.8% 1.9%  
Added value  417.0 -16.2 -248.9 1,029.1 598.0  
Added value %  28.2% -3.0% -19.3% 48.3% 21.6%  
Investments  0 0 0 0 0  

Net sales trend  0.0 -1.0 1.0 2.0 3.0  
EBIT trend  1.0 -1.0 -2.0 1.0 2.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  28.2% -3.0% -19.3% 48.3% 21.6%  
EBIT %  28.2% -3.0% -19.3% 48.3% 21.6%  
EBIT to gross profit (%)  100.0% -5.6% 100.0% 100.0% 88.1%  
Net Earnings %  21.5% -3.8% -16.4% 37.5% 16.5%  
Profit before depreciation and extraordinary items %  21.5% -3.8% -16.4% 37.5% 16.5%  
Pre tax profit less extraordinaries %  27.6% -4.8% -20.7% 48.2% 21.3%  
ROA %  22.0% -1.2% -34.0% 100.5% 47.1%  
ROI %  43.1% -2.3% -103.2% 176.9% 58.1%  
ROE %  86.4% -5.8% -87.8% 149.5% 53.0%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  19.4% 51.1% 17.3% 73.9% 61.5%  
Relative indebtedness %  103.3% 60.9% 50.1% 15.5% 17.9%  
Relative net indebtedness %  54.5% 2.3% 30.5% -10.6% 4.7%  
Net int. bear. debt to EBITDA, %  -29.0% 1,975.3% 101.7% -45.0% -19.7%  
Gearing %  163.1% 0.0% 0.0% 10.0% 31.4%  
Net interest  0 0 0 0 0  
Financing costs %  3.1% 3.7% 0.0% 3.9% 6.2%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.2 1.5 1.0 3.0 1.7  
Current Ratio  1.2 2.0 1.2 3.8 2.6  
Cash and cash equivalent  720.8 320.3 253.2 555.9 366.7  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  182.0 8.9 84.1 71.2 54.8  
Trade creditors turnover (days)  229.1 0.0 1.8 86.3 83.2  
Current assets / Net sales %  128.2% 124.4% 60.6% 59.4% 46.5%  
Net working capital  367.9 347.1 135.3 935.3 793.6  
Net working capital %  24.9% 63.5% 10.5% 43.9% 28.6%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 2,771  
Added value / employee  0 0 0 0 598  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 598  
EBIT / employee  0 0 0 0 598  
Net earnings / employee  0 0 0 0 458